Related Experiment Video
Updated: Nov 27, 2025

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
Published on: October 30, 2018
Immunogenicity study of OmpU subunit vaccine against Vibrio mimicus in yellow catfish, Pelteobagrus fulvidraco
Yu Fu1, Yong-An Zhang1, Jinyu Shen2
1State Key Laboratory of Agricultural Microbiology, College of Fisheries, Huazhong Agricultural University, Wuhan, Hubei, China; Engineering Research Center of Green Development for Conventional Aquatic Biological Industry in the Yangtze River Economic Belt, Ministry of Education, Wuhan, Hubei, China.
Abstract:
The outer membrane protein U (OmpU) is a conserved outer membrane protein in a variety of pathogenic Vibrio species and has been considered as a vital protective antigen for vaccine development. Vibrio mimicus (V. mimicus) is the pathogen causing ascites disease in aquatic animals. In this study, the prokaryotically expressed and purified His-tagged OmpU of V. mimicus (His-OmpU) was used as a subunit vaccine. The formalin inactivated V. mimicus, purified His tag (His-tag), and PBS were used as controls. The vaccinated yellow catfish were challenged with V. mimicus at 28 days post-vaccination, and the results showed that the His-OmpU and inactivated V. mimicus groups exhibited much higher survival rates than the His-tag and PBS groups. To fully understand the underlying mechanism, we detected the expression levels of several immune-related genes in the spleen of fish at 28 days post-vaccination and 24 h post-challenge. The results showed that most of the detected immune-related genes were significantly upregulated in His-OmpU and inactivated V. mimicus groups. In addition, we performed the serum bactericidal activity assay, and the results showed that the serum from His-OmpU and inactivated V. mimicus groups exhibited much stronger bactericidal activity against V. mimicus than those of His-tag and PBS groups. Finally, the serum agglutination antibody was detected, and the antibody could be detected in His-OmpU and inactivated V. mimicus groups with the antibody titers increasing along with the time post-vaccination, but not in His-tag or PBS group. Our data reveal that the recombinant OmpU elicits potent protective immune response and is an effective vaccine candidate against V. mimicus in yellow catfish.
Insights
Outer membrane protein U (OmpU) from Vibrio mimicus serves as an effective subunit vaccine candidate. It significantly boosts survival rates and immune responses in yellow catfish against ascites disease.
Area of Science:
- Aquatic animal immunology
- Vaccine development
- Microbial pathogenesis
Background:
- Outer membrane protein U (OmpU) is a key antigen in pathogenic Vibrio species.
- Vibrio mimicus causes ascites disease in aquatic animals, impacting aquaculture.
- Developing effective vaccines against V. mimicus is crucial for fish health.
Purpose of the Study:
- To evaluate the efficacy of a recombinant OmpU subunit vaccine against V. mimicus in yellow catfish.
- To investigate the immune mechanisms underlying OmpU-mediated protection.
Main Methods:
- Prokaryotic expression and purification of His-tagged OmpU from V. mimicus.
- Vaccination of yellow catfish with His-OmpU, formalin-inactivated V. mimicus, His-tag, and PBS.
- Challenge assay with V. mimicus and survival rate assessment.
- Analysis of immune-related gene expression in fish spleens.
- Serum bactericidal activity and agglutination antibody assays.
Main Results:
- His-OmpU vaccination significantly increased survival rates in yellow catfish challenged with V. mimicus.
- Vaccinated groups showed upregulated immune-related gene expression and enhanced serum bactericidal activity.
- Detectable serum agglutination antibodies were found in His-OmpU and inactivated V. mimicus groups.
Conclusions:
- Recombinant OmpU elicits a potent protective immune response against V. mimicus.
- His-OmpU is a promising subunit vaccine candidate for preventing ascites disease in yellow catfish.
More Related Videos
08:15In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
Published on: December 9, 2022
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020